[Elsevier] LANCET Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes |
|
This post will be closed automatically in 2026-08-03 18:42
Reward10points
|
post
reply
points
2045
10
Effect of MXene reinforcement on bending behavior of glass fiber-epoxy based laminated composites
10
FOX-7 derived nitramines: Novel propellants and oxidizers for solid rocket propulsion
10
Novel and experimental anticoagulant strategies beyond current direct oral anticoagulants
10
Polyimide/aramid nanofiber aerogel-assisted in situ preparation of thermally stabilized polymer electrolytes for all-solid-state lithium-metal batteries
10
Multi-target mechanisms of Chinese herbal medicine in the treatment of allergic rhinitis
